SNGX — Soligenix Income Statement
0.000.00%
- $6.07m
- -$0.38m
- $0.12m
Annual income statement for Soligenix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.36 | 0.824 | 0.949 | 0.839 | 0.119 |
Cost of Revenue | |||||
Gross Profit | 0.538 | 0.096 | 0.398 | 0.097 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 20.9 | 13.5 | 15.2 | 8.93 | 9.56 |
Operating Profit | -18.6 | -12.7 | -14.2 | -8.09 | -9.44 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18.5 | -13.4 | -15 | -7.91 | -8.68 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.7 | -12.6 | -13.8 | -6.14 | -8.27 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.7 | -12.6 | -13.8 | -6.14 | -8.27 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.7 | -12.6 | -13.8 | -6.14 | -8.27 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -154 | -76.7 | -76.9 | -12.1 | -4.98 |